Ronnenberg, Germany

Burkhard Vangerow

This inventor holds 1 USPTO granted patent. Top assignee: Altana Pharma Ag. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Burkhard Vangerow. Retrieved from https://idiyas.com/inventor/burkhard-vangerow

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Burkhard Vangerow: Innovator in Respiratory Treatment

Introduction

Burkhard Vangerow is a notable inventor based in Ronnenberg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of respiratory disorders. His innovative approach combines established medical components to address critical health issues.

Latest Patents

Vangerow holds a patent for a pharmaceutical composition that combines C1 esterase inhibitor (C1-INH) and lung surfactant. This invention is aimed at treating infant respiratory distress syndrome and acute lung injury, including adult respiratory distress syndrome. His patent represents a significant advancement in respiratory treatment options.

Career Highlights

Vangerow is associated with Altana Pharma AG, a company known for its commitment to developing innovative pharmaceutical solutions. His work at Altana Pharma AG has allowed him to focus on groundbreaking research and development in respiratory therapies.

Collaborations

Throughout his career, Vangerow has collaborated with esteemed colleagues such as Dietrich Häfner and Paul-Georg Germann. These partnerships have fostered a collaborative environment that enhances the development of effective medical treatments.

Conclusion

Burkhard Vangerow's contributions to respiratory treatment through his innovative patent highlight his role as a key figure in pharmaceutical advancements. His work continues to impact the medical field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…